Education
About Us
Working with TipRanks
Follow Us
SpectraCure AB (SE:SPEC)
:SPEC
SPEC Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.68 - kr5.11
Previous CloseN/A
Volume60.95K
Average Volume (3M)192.94K
Market Cap
€75.57M
Enterprise ValueN/A
Total Cash (Recent Filing)€18.27M
Total Debt (Recent Filing)kr5.14M
Price to Earnings (P/E)―
Beta-0.87
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding97,131,610
10 Day Avg. Volume200,081
30 Day Avg. Volume192,943
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.55
Price to Sales (P/S)0.00
P/FCF Ratio-4.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
SPEC FAQ
What was SpectraCure AB’s price range in the past 12 months?
SpectraCure AB lowest stock price was kr0.68 and its highest was kr5.11 in the past 12 months.
What is SpectraCure AB’s market cap?
SpectraCure AB’s market cap is €75.57M.
When is SpectraCure AB’s upcoming earnings report date?
SpectraCure AB’s upcoming earnings report date is Aug 21, 2025 which is in 93 days.
How were SpectraCure AB’s earnings last quarter?
SpectraCure AB released its earnings results on Feb 20, 2025. The company reported -kr0.048 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.048.
Is SpectraCure AB overvalued?
According to Wall Street analysts SpectraCure AB’s price is currently Overvalued.
Does SpectraCure AB pay dividends?
SpectraCure AB does not currently pay dividends.
What is SpectraCure AB’s EPS estimate?
SpectraCure AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SpectraCure AB have?
SpectraCure AB has 97,131,610 shares outstanding.
What happened to SpectraCure AB’s price movement after its last earnings report?
SpectraCure AB reported an EPS of -kr0.048 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -18.772%.
Which hedge fund is a major shareholder of SpectraCure AB?
Currently, no hedge funds are holding shares in SE:SPEC
---
Company Description
SpectraCure AB
SpectraCure AB (SPEC) is a medical technology company focused on developing innovative cancer treatment solutions. The company specializes in photodynamic therapy (PDT), a minimally invasive treatment method that uses laser technology to activate a photosensitive drug for the effective targeting and destruction of cancer cells. SpectraCure primarily targets hard-to-treat cancers, such as prostate cancer, with its proprietary Interstitial Photodynamic Therapy (IPDT) system designed to improve patient outcomes and reduce side effects associated with traditional cancer treatments.
---
Technical Analysis
Acarix AB
―
Clinical Laserthermia Systems AB Class B
―
Q-linea AB
―
SciBase Holding AB
―
Scandinavian Real Heart AB
―
---